cloricromen has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boveris, A; Ferreira, R; Grana, D; Llesuy, S; Milei, J; Prosdocimi, M | 1 |
| de Gaetano, G; Dejana, E; Finesso, M; Gorio, A; Languino, LR; Prosdocimi, M; Tessari, F | 1 |
2 other study(ies) available for cloricromen and Coronary Disease
| Article | Year |
|---|---|
Reduction of myocardial damage by cloricromene during ischemia-reperfusion in the rabbit.
Topics: Animals; Chromonar; Coronary Disease; Electrocardiography; Heart; In Vitro Techniques; Luminescent Measurements; Mice; Models, Biological; Myocardial Reperfusion Injury; Myocardium; Peroxides; Rabbits; Rats; Rats, Inbred Strains; tert-Butylhydroperoxide | 1992 |
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Chromonar; Collagen; Coronary Disease; Coumarins; Disease Models, Animal; Dogs; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Regional Blood Flow; Thromboxane B2 | 1985 |